End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
770,000 KRW | -0.90% | -1.41% | +1.32% |
07:14am | US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz | MT |
May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.32% | 40.49B | |
-1.62% | 89.22B | |
-15.61% | 32.79B | |
+64.13% | 26.23B | |
-21.62% | 14.52B | |
-7.92% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B | |
-13.45% | 7.92B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics Boosts Contract Size with MSD Switzerland